Novo Nordisk Production Belgium SA
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Font Saint Landry 10, Brussels, - 1120, Belgium (BEL)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3007647000 · DUNS 370696762
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-04-07
- VAIDrug Quality Assurance2022-08-19
- VAIDrug Quality Assurance2020-01-22
- VAIVaccines and Allergenic Products2019-06-19
- VAIVaccines and Allergenic Products2017-07-07
- VAIDrug Quality Assurance2016-11-25
- VAIVaccines and Allergenic Products2015-05-28
- VAIDrug Quality Assurance2015-02-13
- VAIDrug Quality Assurance2013-01-30
- VAIVaccines and Allergenic Products2011-06-10
- VAIVaccines and Allergenic Products2009-07-20
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- bremelanotideCosette Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.